Top Markets
#1 Islamic Coin Islamic Coin +151.54%
#2 Akedo Akedo +68.63%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +48.64%
#5 Velvet Velvet +39.32%
#6 Black Phoenix Black Phoenix +34.14%
#7 Cross Cross +31.00%
#8 Cap Cap +18.34%
#9 DoubleZero DoubleZero +13.97%
#10 Pieverse Pieverse +10.78%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Burzynski Research Institute, Inc. Burzynski Research Institute, Inc.

Burzynski Research Institute, Inc.

BZYR
Rank in Stocks #39233
Burzynski Research Institute, Inc. engages in the research and development of... Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.
Share Price
$0.0045
Last synced: 2026-08-13
Market Cap
$591.52K
Change (1 day)
-10.00%
Change (1 year)
-86.76%
Country
US
Trade Burzynski Research Institute, Inc. (BZYR)

Category

Healthcare
Revenue for Burzynski Research Institute, Inc. (BZYR)
Revenue in Aug 2026 TTM: 0
According to Burzynski Research Institute, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Burzynski Research Institute, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US